Experience in Switching Monoclonal Antibodies in a Patient With Severe Refractory Atopic Dermatitis: From Dupilumab to Abrocitinib. Case Report . Rev Alerg Mex 2025, 72 (4), 382-385. https://doi.org/10.29262/ram.v72i4.1547.